Sun Pharma Advanced Research Company said its net loss for the quarter ended September 2015 has widened to Rs 177.40. It reported a net loss of Rs 14.70 million in the same quarter previous year.
Revenues for the quarter declined 7.00% to Rs 433.30 million, compared with Rs 465.90 million for the prior year period.
Quarterly Results - Standalone (Rs in mn) |
As at | Sep - 15 | Sep - 14 | %Change |
Revenues | 433.30 | 465.90 | (7.00) |
Net Profit | (177.40) | (14.70) | - |
Diluted EPS | NA | NA | |
Shares of the company declined Rs 7.75, or 1.99%, to settle at Rs 381.85. The total volume of shares traded was 346,377 at the BSE (Wednesday).